Is Vyndamax recommended in ATTR-CM treatment guidelines?
Note: Both statements are the manufacturer's summaries on the Vyndamax HCP efficacy page; the guideline texts, including the population and level of evidence of each recommendation, were not captured. The 2022 document is a heart failure guideline, and the 2025 document is an ACC concise clinical guidance on transthyretin cardiac amyloidosis.